STOCK TITAN

100K JNJ shares set for Rule 144 sale by shareholder (JNJ)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of JNJ common stock filed a notice of proposed sale of 100,000 shares under Rule 144. The shares are to be sold through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $22,014,000 based on the figures in the notice. As context, the filing lists 2,409,295,102 JNJ common shares outstanding. The planned sale date is approximately 01/26/2026.

The 100,000 shares of common stock were acquired on 03/18/2025 via a transfer from Joaquin Duoto, who originally received the shares as compensation between 02/12/2021 and 02/13/2023. The form also includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many JNJ shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 100,000 shares of JNJ common stock.

What is the approximate market value of the JNJ shares to be sold?

The filing lists an aggregate market value of $22,014,000 for the 100,000 JNJ common shares to be sold.

When is the planned sale date for the JNJ shares in this Form 144?

The approximate date of sale given in the notice is 01/26/2026.

How many JNJ shares are listed as outstanding in this Form 144 notice?

The form states there are 2,409,295,102 JNJ common shares outstanding.

How and when were the JNJ shares in this Form 144 acquired?

The 100,000 JNJ common shares were acquired on 03/18/2025 via a transfer from Joaquin Duoto, who obtained them as compensation between 02/12/2021 and 02/13/2023.

Which broker is handling the proposed JNJ share sale under this Form 144?

The proposed sale will be handled by J.P. Morgan Securities LLC, located at 270 Park Avenue, 10th Floor, New York, NY 10017.

Does the Form 144 filer make any representation about undisclosed adverse information on JNJ?

Yes. By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Johnson & Johnson

NYSE:JNJ

View JNJ Stock Overview

JNJ Rankings

JNJ Latest News

JNJ Latest SEC Filings

JNJ Stock Data

566.92B
2.41B
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NEW BRUNSWICK